197 related articles for article (PubMed ID: 34584095)
1. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
Bocci T; Prenassi M; Arlotti M; Cogiamanian FM; Borellini L; Moro E; Lozano AM; Volkmann J; Barbieri S; Priori A; Marceglia S
NPJ Parkinsons Dis; 2021 Sep; 7(1):88. PubMed ID: 34584095
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Electrical Energy Delivered by Deep Brain Stimulation and Levodopa-Induced Dyskinesias in Parkinson's Disease: A Retrospective Preliminary Analysis.
Prenassi M; Arlotti M; Borellini L; Bocci T; Cogiamanian F; Locatelli M; Rampini P; Barbieri S; Priori A; Marceglia S
Front Neurol; 2021; 12():643841. PubMed ID: 34135846
[No Abstract] [Full Text] [Related]
3. Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson's disease.
He S; Baig F; Merla A; Torrecillos F; Perera A; Wiest C; Debarros J; Benjaber M; Hart MG; Ricciardi L; Morgante F; Hasegawa H; Samuel M; Edwards M; Denison T; Pogosyan A; Ashkan K; Pereira E; Tan H
Brain; 2023 Dec; 146(12):5015-5030. PubMed ID: 37433037
[TBL] [Abstract][Full Text] [Related]
4. Adaptive deep brain stimulation for Parkinson's disease: looking back at the past decade on motor outcomes.
An Q; Yin Z; Ma R; Fan H; Xu Y; Gan Y; Gao Y; Meng F; Yang A; Jiang Y; Zhu G; Zhang J
J Neurol; 2023 Mar; 270(3):1371-1387. PubMed ID: 36471098
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of adaptive Deep Brain Stimulation in Parkinson's disease.
Piña-Fuentes D; van Dijk JMC; van Zijl JC; Moes HR; van Laar T; Oterdoom DLM; Little S; Brown P; Beudel M
Brain Stimul; 2020; 13(6):1507-1516. PubMed ID: 32738409
[TBL] [Abstract][Full Text] [Related]
6. At home adaptive dual target deep brain stimulation in Parkinson's disease with proportional control.
Schmidt SL; Chowdhury AH; Mitchell KT; Peters JJ; Gao Q; Lee HJ; Genty K; Chow SC; Grill WM; Pajic M; Turner DA
Brain; 2024 Mar; 147(3):911-922. PubMed ID: 38128546
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic nucleus deep brain stimulation driven by primary motor cortex γ2 activity in parkinsonian monkeys.
Darbin O; Hatanaka N; Takara S; Kaneko N; Chiken S; Naritoku D; Martino A; Nambu A
Sci Rep; 2022 Apr; 12(1):6493. PubMed ID: 35444245
[TBL] [Abstract][Full Text] [Related]
8. Adaptive deep brain stimulation as advanced Parkinson's disease treatment (ADAPT study): protocol for a pseudo-randomised clinical study.
Piña-Fuentes D; Beudel M; Little S; Brown P; Oterdoom DLM; van Dijk JMC
BMJ Open; 2019 Jun; 9(6):e029652. PubMed ID: 31201193
[TBL] [Abstract][Full Text] [Related]
9. Bilateral adaptive deep brain stimulation is effective in Parkinson's disease.
Little S; Beudel M; Zrinzo L; Foltynie T; Limousin P; Hariz M; Neal S; Cheeran B; Cagnan H; Gratwicke J; Aziz TZ; Pogosyan A; Brown P
J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):717-21. PubMed ID: 26424898
[TBL] [Abstract][Full Text] [Related]
10. Single threshold adaptive deep brain stimulation in Parkinson's disease depends on parameter selection, movement state and controllability of subthalamic beta activity.
Busch JL; Kaplan J; Habets JGV; Feldmann LK; Roediger J; Köhler RM; Merk T; Faust K; Schneider GH; Bergman H; Neumann WJ; Kühn AA
Brain Stimul; 2024; 17(1):125-133. PubMed ID: 38266773
[TBL] [Abstract][Full Text] [Related]
11. Efficient suppression of parkinsonian beta oscillations in a closed-loop model of deep brain stimulation with amplitude modulation.
Bahadori-Jahromi F; Salehi S; Madadi Asl M; Valizadeh A
Front Hum Neurosci; 2022; 16():1013155. PubMed ID: 36776221
[TBL] [Abstract][Full Text] [Related]
12. Adaptive deep brain stimulation in advanced Parkinson disease.
Little S; Pogosyan A; Neal S; Zavala B; Zrinzo L; Hariz M; Foltynie T; Limousin P; Ashkan K; FitzGerald J; Green AL; Aziz TZ; Brown P
Ann Neurol; 2013 Sep; 74(3):449-57. PubMed ID: 23852650
[TBL] [Abstract][Full Text] [Related]
13. Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease.
Marceglia S; Conti C; Svanidze O; Foffani G; Lozano AM; Moro E; Volkmann J; Arlotti M; Rossi L; Priori A
BMJ Open; 2022 Jan; 12(1):e049955. PubMed ID: 34980610
[TBL] [Abstract][Full Text] [Related]
14. Low-frequency oscillation suppression in dystonia: Implications for adaptive deep brain stimulation.
Piña-Fuentes D; Beudel M; Van Zijl JC; Van Egmond ME; Oterdoom DLM; Van Dijk JMC; Tijssen MAJ
Parkinsonism Relat Disord; 2020 Oct; 79():105-109. PubMed ID: 32919097
[TBL] [Abstract][Full Text] [Related]
15. On-Off and Proportional Closed-Loop Adaptive Deep Brain Stimulation Reduces Motor Symptoms in Freely Moving Hemiparkinsonian Rats.
Evers J; Orłowski J; Jahns H; Lowery MM
Neuromodulation; 2024 Apr; 27(3):476-488. PubMed ID: 37245140
[TBL] [Abstract][Full Text] [Related]
16. Controlling Parkinson's disease with adaptive deep brain stimulation.
Little S; Pogosyan A; Neal S; Zrinzo L; Hariz M; Foltynie T; Limousin P; Brown P
J Vis Exp; 2014 Jul; (89):. PubMed ID: 25077449
[TBL] [Abstract][Full Text] [Related]
17. An external portable device for adaptive deep brain stimulation (aDBS) clinical research in advanced Parkinson's Disease.
Arlotti M; Rossi L; Rosa M; Marceglia S; Priori A
Med Eng Phys; 2016 May; 38(5):498-505. PubMed ID: 27029510
[TBL] [Abstract][Full Text] [Related]
18. Adaptive delivery of continuous and delayed feedback deep brain stimulation - a computational study.
Popovych OV; Tass PA
Sci Rep; 2019 Jul; 9(1):10585. PubMed ID: 31332226
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
20. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
Arlotti M; Marceglia S; Foffani G; Volkmann J; Lozano AM; Moro E; Cogiamanian F; Prenassi M; Bocci T; Cortese F; Rampini P; Barbieri S; Priori A
Neurology; 2018 Mar; 90(11):e971-e976. PubMed ID: 29444973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
